Produktbild: Molecular Targets in Cancer Therapy
- 10%

Molecular Targets in Cancer Therapy Understanding Cellular Pathways for Therapeutic Interventions

10% sparen

162,99 € UVP 181,89 €

inkl. MwSt, Versandkostenfrei

Lieferung nach Hause

Beschreibung

Details

Einband

Gebundene Ausgabe

Erscheinungsdatum

24.06.2025

Herausgeber

Anand Shankar Ramteke + weitere

Verlag

Springer Singapore

Seitenzahl

272

Maße (L/B/H)

24,1/16/2,1 cm

Auflage

1. Auflage

Sprache

Englisch

ISBN

978-981-9673-35-3

Beschreibung

Portrait

Dr. Anand Shankar Ramteke

Anand Shankar Ramteke did his doctorate in Life Sciences from Jawaharlal Nehru University, New Delhi, India with a specialization in the area of radiation and cancer biology. He has been working in the area of exosome biology, tumor microenvironment and drug resistance in head and neck, breast and prostate cancers. His research interest also includes developing a nano-bio system for targeted drug delivery for cancer therapy. Presently he is working as a Professor at Tezpur University, Tezpur, Assam, India. and has published high impact papers in the field. He was also a visiting Professor/Faculty at the University of Oklahoma Health Sciences, Oklahoma, USA and the University of Colorado, Denver, USA.

 

Dr. Suresh Kumar Ramakrishnan

Suresh Kumar Ramakrishnan did his doctorate in Life Sciences from Jawaharlal Nehru University, New Delhi India. He worked in the field of non-canonical function of telomerase in cancer cells and unraveled telomerase RNA function in controlling cellular physiology. His interest also lies in epigenetic modifications, drug resistance, and chemoprevention in cancers. He was a visiting scientist at The Wistar Institute, Philadelphia, USA and worked in the field of non-coding RNAs in cancer. Presently he is working as a Scientist F at ICMR-National Institute of Cancer Prevention and Research, Noida, Uttar Pradesh, India. 

Dr. Rajesh Agarwal

Rajesh Agarwal graduated from Lucknow University, Lucknow, India and worked at several positions in India and CWRU, Cleveland, USA. Presently he is working as a Professor in the Department of Pharmaceutical Sciences, School of Pharmacy, University of Colorado, Anschutz Medical Campus (UC-AMC), Aurora, CO, USA. He is a pioneer in cancer pharmacology and chemoprevention and has published more than 400 research papers in high impact journals. He is a fellow of the American Association for the Advancement of Science, and a recipient of several national and international awards.

Details

Einband

Gebundene Ausgabe

Erscheinungsdatum

24.06.2025

Herausgeber

Verlag

Springer Singapore

Seitenzahl

272

Maße (L/B/H)

24,1/16/2,1 cm

Auflage

1. Auflage

Sprache

Englisch

ISBN

978-981-9673-35-3

Herstelleradresse

Springer-Verlag KG
Sachsenplatz 4-6
1201 Wien
AT

Email: ProductSafety@springernature.com

Unsere Kundinnen und Kunden meinen

0 Bewertungen

Informationen zu Bewertungen

Zur Abgabe einer Bewertung ist eine Anmeldung im Konto notwendig. Die Authentizität der Bewertungen wird von uns nicht überprüft. Wir behalten uns vor, Bewertungstexte, die unseren Richtlinien widersprechen, entsprechend zu kürzen oder zu löschen.

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kund*innen durch Ihre Meinung

Unsere Kundinnen und Kunden meinen

0 Bewertungen filtern

  • Produktbild: Molecular Targets in Cancer Therapy
  • .- Chapter 1: Structural features and Signaling mechanisms of Receptor Tyrosine Kinases in Cancer

    .- Chapter 2: Cell Death Pathways in Cancer and Potential Therapeutic Targets

    .- Chapter 3: Telomerase as a Target for Cancer Therapy  

    .- Chapter 4: Molecular targets of epigenetic regulators

    .- Chapter 5: Signaling Pathways in Cancer Drug Resistance: Potential Targets for Therapeutic Intervention  

    .- Chapter 6: Targeting Angiogenesis for Cancer Prevention and Therapy     

    .- Chapter 7: Inflammation as a target in cancer therapy

    .- Chapter 8: Epithelial-Mesenchymal Transition: Insights into Molecular Pathways and Cancer Therapeutics

    .- Chapter 9: Targeting Metabolic Reprogramming: A New Frontier in Cancer Therapy 

    .- Chapter 10:Genomic instability as a Therapeutic Target: Advancements from Experimental Research to Clinical Application

    .- Chapter 11:Targeting innate immunity: A New Door to Cancer Therapy 

    .- Chapter 12:Metabolic Targeting in Cancer Therapy: Strategies, Challenges, and Personalized Approaches.